Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c842
Identifier NCT04925973
Trial Title Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis Acute
Interventions DRUG: Tofacitinib 10 MG [Xeljanz]
Participant Information
Sponsor McMaster University
City Hamilton
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2021-06-01
Primary Completion Date 2025-12-23
Completion Date 2025-12-23